Author and year
Original diagnosis for RT Mean age (yrs.)* F/M Mean RT dose (Gy) Mean latency (yrs.) Histology WHO grade Mean follow-up (yrs.) Recurrence Harrison et al., 1991 [5 ] 7 2, tinea capitis 1, presumed sarcoma 1. prepubertal gigantism 1, thalamic glioma 1, keloid 1, astrocytoma 53.4 5/2 — 42.7 3, atypical 2, meningothelial 1, transitional 1, mixed (meningothelial, transitional, fibroblastic) — — 3 (42.9%) Salvati et al., 1996 [29 ] 10 4, ALL 2, medulloblastoma 2, adenoma 1, carcinoma 1, astrocytoma 30.4 7/3 39.8 16.9 4, atypical 4, fibroblastic 1, meningothelial 1, transitional — — 1 (10%) Sadetzki et al., 2002 [30 ] 253† 253, tinea capitis 43.6 1.9 : 1 — 36.3 183, NOS 63, meningothelial 38, transitional 31, fibroblastic 4, angioblastic 2, psammomatous 1, malignant 6, mixed — 9.8 18.2% De Tommasi et al., 2005 [31 ] 6 6, tinea capitis 57.7 4/2 15 40.2 2, meningothelial 2, transitional 1, choroid 1 atypical 4, I 2, II — 0 Banerjee et al., 2009 [32 ] 8 8, ALL 26.5 5/3 26.5 23 3, meningothelial 2, fibroblastic 2, transitional 1, atypical 7, I 1, II — 2 (25%) Godlewski et al., 2012 [33 ] 19 4, ALL 3, NHL 3, astrocytoma 2, ependymoma 1, pituitary adenoma 1, medulloblastoma 1, “brain tumor” 1, CNS lymphoma 1, leukemia 1, germinoma 1, ganglioneuroblastoma 35.7 12/7 31.9 25.9 — 17, I 1, II 1, N/A 5.8 4 (21.1%)